Chapter 30: Acute Coronary Syndromes Flashcards

1
Q

An acute coronary syndrome results from ____ buildup in the _____ (coronary atherosclerosis).

A

plaque

coronary arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Plaque buildup can rupture, leading to ____ formation and _____ to the heart.

A

thrombus

ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors that lead to plaque buildup that causes an ACS

A
  • Age: men > 45 years, women > 55 years (or early hysterectomy
  • Family hx: 1st degree relative w/ coronary event before 55 years (men) or 65 years (women)
  • Smoking
  • HTN
  • Known coronary artery disease
  • Dyslipidemia
  • Diabetes
  • Chronic angina
  • Lack of exercise
  • Excessive alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Classic signs and symptoms of ACS

A

chest pain (pressure and squeezing) lasting > 10 min, severe dyspnea, diaphoresis, syncope/presyncope, and/or palpitations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pain from ACS can radiate to

A

arms, back, neck, jaw, or epigastric region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Patients with a prescription for SL nitroglycerin should use __ dose(s) every __ min up to ___ doses for relief of chest pain. If the pain is not improved or is worse __ min after the first dose, call 911 immediately

A

one dose every 5 min up to 3 doses

5 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NSTE-ACS describes which 2 medical conditions

A

Unstable angina & NSTEMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cardiac enzymes in unstable angina are (neg/pos)
Cardiac enzymes in NSTEMI are (neg/pos)
Cardiac enzymes in STEMI are (neg/pos)

A

UA - negative
NSTEMI - Positive
STEMI - Positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
There is (partial/complete) blockage in unstable angina
There is (partial/complete) blockage in NSTEMI
There is (partial/complete) blockage in STEMI
A

UA - partial
NSTEMI - partial
STEMI - complete

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

___ should be performed and evaluated within 10 minutes at the site of first medical contact after ACS

A

A 12-lead ECG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Patients with STEMI or NSTEMI should be urgently transported to a hospital with _____ capability, if possible

A

percutaneous coronary intervention (PCI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the most sensitive and specific biomarkers for ACS

A

Cardiac troponins I & T (TnI and TnT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When should cardiac troponin levels be obtained in all patients with ACS symptoms

A

At presentation & 3-6 hours after symptom onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is PCI

A

a coronary revascularization procedure that involves inflating a small balloon inside a coronary artery to widen it and improve blood flow. Usually, a metal stent is placed into the artery after to keep it open

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In STEMI, the blocked arteries need to be opened how quickly

A

as quickly as possible with PCI (preferred) or fibrinolytics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acute treatment of ACS is aimed at

A

Immediate relief of ischemia & preventing MI expansion and death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Drug treatment for ACS

A
  • remember MONA-GAP-BA*
  • Morphine
  • Oxygen
  • Nitrates
  • Aspirin
  • GPIIb/IIIa antagonists
  • Anticoagulants
  • P2Y12 inhibitors
  • Beta-blockers
  • ACE inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which antianginals are used in ACS

A

Morphine, BB, nitrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

MOA of antianginals in ACS

A

Decrease myocardial O2 demand or increase myocardial O2 supply (blood flow) to relieve ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

MOA of antiplatelets in ACS

A

Inhibit platelet aggregation to prevent clot formation/growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MOA of anticoagulants in ACS

A

inhibit clotting factors to prevent clot formation/growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

NSTE-ACS (i.e, NSTEMI and unstable angina) are treated with:

A

MONA-GAP-BA +/- PCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

STEMI is treated with

A

MONA-GAP-BA + PCI (preferred) or fibrinolytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When should morphine, O2, nitrates and ASA (MONA) be given

A

Immediately as needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
MOA of morphine in ACS
Antianginal; produces arterial and venous dilation (↓ preload and afterload) Provides pain relief
26
MOA of nitrates in ACS
Antianginal: dilates coronary arteries and improves collateral blood flow; ↓ preload and afterload (modestly); reduces chest pain
27
Which dose and formulation of NTG should be administered in ACS
SL 0.4 mg
28
Which drug class is CI with nitrates
PDE5-i
29
Which dose and formulation of aspirin should be administered in ACS
Non-EC, chewable ASA | 162-325 mg
30
Do not use which formulation of ASA in ACS
extended release
31
What is the maintenance dose of ASA that should be continued indefinitely in ACS
81-162 mg daily
32
Which drugs are GPIIb/IIIa receptor antagonists
abciximab, eptifibatide, and tirofiban
33
Which anticoagulant is preferred for STEMI
bivalirudin
34
Which anticoagulants are used in ACS
LMWHs (e.g. enoxaparin, dalteparin), UFH and bivalirudin
35
Which P2Y12 inhibitors are used in ACS
clopidogrel, prasugrel, and ticagrelor
36
Which drugs are given within 24 hrs (as needed) in ACS & continued as outpatient
BB and ACEi
37
Why are BB used in ACS
they increase long-term survival
38
Which type of BB is preferred in ACS
oral low dose BB (B1 selective blocker without intrinsic sympathomimetic activity preferred)
39
Which BB do have ISA & should be avoided post-MI
Acebutolol, penbutolol and pindolol
40
Which two drugs are continued indefinitely post ACS
BB & ACEi (in pts with LVEF < 40%, HTN, DM, or stable CKD)
41
Which medications should be avoided in ACS
- NSAIDs (except ASA) should not be administered during hospitalization - IR nifedipine d/t increased risk of mortality
42
MOA of aspirin
inhibits platelet aggregation/clot formation by inhibiting production of TXA2 via irreversible COX1 and COX2 inhibition
43
MOA of P2Y12 inhibitors
bind to the ADP P2Y12 receptor on the platelet surface which prevents ADP-mediated activation of the GPIIb/IIIa receptor complex, thereby reducing platelet aggregation
44
GPIIb/IIIa receptor antagonists MOA
block the platelet glycoprotein IIb/IIIa receptor, which is the binding site for fibrinogen, vWf and other ligands, thereby ↓ plt aggregation and further thrombosis
45
Vorapaxar MOA
PAR-1 antagonist that reversibly binds to the PAR-1 expressed on platelets, preventing thrombin-induced and thrombin receptor agonist peptide-induced platelet aggregation
46
Which two P2Y12 inhibitors are prodrugs that irreversibly bind to the receptor
Clopidogrel and prasugrel
47
Clopidogrel and prasugrel are classified as
thienopyridines
48
P2Y12 inhibitors are commonly used with ___ after ACS
Aspirin
49
Clopidogrel maintenance dose
75 mg PO daily | note: a much higher loading dose is required either prior to PIC or at the time of dx if PCI is not performed
50
Clopidogrel effectiveness depends on the conversion to _____, mainly by which CYP enzyme?
an active metabolite | 2C19
51
Clopidogrel CI
active serious bleeding
52
Clopidogrel should be stopped ___ days prior to elective surgery
5
53
Do not use clopidogrel with these 2 drugs d/t severe drug interaction
Omeprazole and esomeprazole
54
All P2Y12 inhibitors can cause
Thrombotic thrombocytopenic purpura (TTP)
55
Prasugrel brand name
Effient
56
Which P2Y12 inhibitor must be dispensed in its original container to protect from moisture
Prasugrel
57
Ticagrelor brand name
Brillinta
58
Which P2Y12 inhibitor comes as an injection
Cangrelor
59
Ticagrelor maintenance dose
90 mg PO BID for 1 year, then 60 mg BID
60
Prasugrel CI
Active serious bleeding, history of TIA or stroke
61
Prasugrel should be stopped ___ days prior to elective surgery
7
62
If using Ticagrelor, after the initial dose of 162-325 mg of ASA, do not exceed aspirin ___ mg for maintenance doses because higher daily doses can reduce the effectiveness of ticagrelor
100 mg
63
Ticagrelor should be stopped ___ days prior to any surgery
5
64
Besides bleeding, what is another side effect of ticagrelor
Dyspnea | think of a tiger chasing you and you're out of breath
65
Which drugs can increase the risk of bleeding and should be avoided with P2Y12 inhibitors
NSAIDs, SSRI, SNRI, and warfarin
66
Abciximab brand name
ReoPro (a pro with abs)
67
Eptifibatide brand name
Integrilin
68
Side effect of GPIIb/IIIa receptor antagonists
Bleeding, thrombocytopenia
69
MOA of fibrinolytics
cause fibrinolysis (clot breakdown) by binding to fibrin and converting plasminogen to plasmin
70
Fibrinolytics are only used for
STEMI
71
PCI for STEMI is preferred if it can be performed within __ minutes (optimal door-to-balloon time) or within __ minutes of first medical contact (which could be in an ambulance)
90 | 120
72
If PCI is not possible, fibrinolytic therapy is recommended for STEMI and should be given within __ min of hospital arrival (door-to-needle time)
30
73
Which drugs are fibrinolytics
Alteplase (tPA) and tenecteplase
74
Alteplase brand name
``` Activase Cathflo Activase (single-use 2 mg vial) ```
75
tenecteplase brand name
TNKase
76
Fibrinolytic CI
Active internal bleeding history of recent stroke severe uncontrolled HTN
77
Alteplase CI and dosing differ for which condition
ischemic stroke
78
Drugs used for secondary prevention after ACS & duration
- Aspirin 81 mg/day indefinitely - P2Y12 inhibitor - NTG indefinitely - BB: 3 years; indefinitely if HF or if needed for HTN - ACEi indefinitely if EF < 40%, HTN, CKD or diabetes - Aldosterone antagonist if EF = 40% and either sx HF or DM receiving target doses of an ACEi and BB - High-intensity Statin indefinitely
79
Aldosterone antagonist CI
significant renal impairment (SCr > 2.5 mg/dl in men, SCr > 2 mg/dl in women) or hyperkalemia (K > 5 mEq/L)
80
Which P2Y12 inhibitors can a patient who was treated with PCI receive (including any type of stent) for secondary prevention after ACS
Clopidogrel, prasugrel or ticagrelor with ASA 81 mg for at least 12 months
81
Continuation of dual antiplatelet therapy beyond 12 months can be considered in pts who received a PCI or stent in which pts
Pts who are tolerating DAPT and are not at high risk of bleeding following coronary stent placement
82
Which P2Y12 inhibitors can a patient who received fibrinolytics receive for secondary prevention after ACS
Ticagrelor or clopidogrel with ASA 81 mg for at least 12 months
83
Which NSAID can be used for pain relief after ACS
Naproxen (lowest CV risk)
84
Which NSAIDs should be avoided after ACS since they have high CV risk
COX-2 selective NSAIDs (Bextra, Celebrex, and Vioxx)
85
Which drug class should be prescribed in any patient with a history of GI bleeding while taking triple antithrombotic therapy
PPIs